Kolon TissueGene Statistics

Total Valuation

KOSDAQ:950160 has a market cap or net worth of KRW 3.20 trillion. The enterprise value is 3.18 trillion.

Market Cap	3.20T
Enterprise Value	3.18T

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:950160 has 83.00 million shares outstanding. The number of shares has increased by 9.92% in one year.

Current Share Class	n/a
Shares Outstanding	83.00M
Shares Change (YoY)	+9.92%
Shares Change (QoQ)	+0.35%
Owned by Insiders (%)	15.30%
Owned by Institutions (%)	0.00%
Float	27.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	620.64
PB Ratio	17.40
P/TBV Ratio	17.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-88.66
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-93.18

Financial Position

The company has a current ratio of 0.51, with a Debt / Equity ratio of 0.19.

Current Ratio	0.51
Quick Ratio	0.45
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	-1.05
Interest Coverage	-274.33

Financial Efficiency

Return on equity (ROE) is -23.89% and return on invested capital (ROIC) is -8.46%.

Return on Equity (ROE)	-23.89%
Return on Assets (ROA)	-6.44%
Return on Invested Capital (ROIC)	-8.46%
Return on Capital Employed (ROCE)	-12.27%
Revenue Per Employee	177.55M
Profits Per Employee	-1.24B
Employee Count	29
Asset Turnover	0.02
Inventory Turnover	82.11

Taxes

Income Tax	-95.84M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +143.80% in the last 52 weeks. The beta is -0.81, so KOSDAQ:950160's price volatility has been lower than the market average.

Beta (5Y)	-0.81
52-Week Price Change	+143.80%
50-Day Moving Average	41,028.00
200-Day Moving Average	34,853.40
Relative Strength Index (RSI)	46.19
Average Volume (20 Days)	215,857

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:950160 had revenue of KRW 5.15 billion and -35.85 billion in losses. Loss per share was -452.29.

Revenue	5.15B
Gross Profit	542.11M
Operating Income	-23.17B
Pretax Income	-35.94B
Net Income	-35.85B
EBITDA	-22.41B
EBIT	-23.17B
Loss Per Share	-452.29

Full Income Statement

Balance Sheet

The company has 53.22 billion in cash and 35.75 billion in debt, giving a net cash position of 17.47 billion or 210.50 per share.

Cash & Cash Equivalents	53.22B
Total Debt	35.75B
Net Cash	17.47B
Net Cash Per Share	210.50
Equity (Book Value)	183.69B
Book Value Per Share	2,287.16
Working Capital	-58.76B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -33.97 billion and capital expenditures -138.55 million, giving a free cash flow of -34.11 billion.

Operating Cash Flow	-33.97B
Capital Expenditures	-138.55M
Free Cash Flow	-34.11B
FCF Per Share	-410.91

Full Cash Flow Statement

Margins

Gross Margin	10.53%
Operating Margin	-450.07%
Pretax Margin	-698.05%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:950160 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.92%
Shareholder Yield	n/a
Earnings Yield	-1.12%
FCF Yield	-1.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:950160 has an Altman Z-Score of 5.43 and a Piotroski F-Score of 2.

Altman Z-Score	5.43
Piotroski F-Score	2